Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3Phase NA 2Phase 4 1Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Waldenstrom Macroglobulinemia 1Sexuality 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Postoperative Complications 1Neurologic Manifestations 1Infertility 1Glioma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Sildenafil Citrate × Clear all
NCT01817751 2024-07-17

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Virginia Commonwealth University

Phase 2 Completed
47 enrolled 13 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neurologic Manifestations

NCT00080808 2012-07-30

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
111 enrolled
GenitourinaryOther

Infertility, Postoperative Complications, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Sexuality

NCT00165295 2011-06-27

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute

Phase 2 Completed
30 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡